Katharine A. Collier

Katharine A. Collier's research focuses on genitourinary cancers, particularly kidney (renal cell carcinoma), prostate, and bladder cancers, with an emphasis on evaluating drug treatments such as immune checkpoint inhibitors, cabozantinib, and PARP inhibitors like olaparib. Her work also explores mechanisms of drug resistance and potential molecular targets for cancer therapy, often through multicenter clinical studies. This research combines clinical oncology data with molecular biology to inform treatment strategies for advanced cancers.

Publication output increased notably around 2020-2021 and has remained relatively high and steady since, averaging about 9-10 papers per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026